BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33298956)

  • 1. Blood and lymphatic systems are segregated by the FLCN tumor suppressor.
    Tai-Nagara I; Hasumi Y; Kusumoto D; Hasumi H; Okabe K; Ando T; Matsuzaki F; Itoh F; Saya H; Liu C; Li W; Mukouyama YS; Marston Linehan W; Liu X; Hirashima M; Suzuki Y; Funasaki S; Satou Y; Furuya M; Baba M; Kubota Y
    Nat Commun; 2020 Dec; 11(1):6314. PubMed ID: 33298956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis.
    Harada K; Yamazaki T; Iwata C; Yoshimatsu Y; Sase H; Mishima K; Morishita Y; Hirashima M; Oike Y; Suda T; Miura N; Watabe T; Miyazono K
    J Cell Sci; 2009 Nov; 122(Pt 21):3923-30. PubMed ID: 19825936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox18 induces development of the lymphatic vasculature in mice.
    François M; Caprini A; Hosking B; Orsenigo F; Wilhelm D; Browne C; Paavonen K; Karnezis T; Shayan R; Downes M; Davidson T; Tutt D; Cheah KS; Stacker SA; Muscat GE; Achen MG; Dejana E; Koopman P
    Nature; 2008 Dec; 456(7222):643-7. PubMed ID: 18931657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonvenous origin of dermal lymphatic vasculature.
    Martinez-Corral I; Ulvmar MH; Stanczuk L; Tatin F; Kizhatil K; John SW; Alitalo K; Ortega S; Makinen T
    Circ Res; 2015 May; 116(10):1649-54. PubMed ID: 25737499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prox1, master regulator of the lymphatic vasculature phenotype.
    Hong YK; Detmar M
    Cell Tissue Res; 2003 Oct; 314(1):85-92. PubMed ID: 12883994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium.
    Murtomaki A; Uh MK; Choi YK; Kitajewski C; Borisenko V; Kitajewski J; Shawber CJ
    Development; 2013 Jun; 140(11):2365-76. PubMed ID: 23615281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic endothelial cell fate specification in the mammalian embryo: An historical perspective.
    Oliver G
    Dev Biol; 2022 Feb; 482():44-54. PubMed ID: 34915023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves.
    Srinivasan RS; Oliver G
    Genes Dev; 2011 Oct; 25(20):2187-97. PubMed ID: 22012621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph sacs are not required for the initiation of lymph node formation.
    Vondenhoff MF; van de Pavert SA; Dillard ME; Greuter M; Goverse G; Oliver G; Mebius RE
    Development; 2009 Jan; 136(1):29-34. PubMed ID: 19060331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells.
    Srinivasan RS; Geng X; Yang Y; Wang Y; Mukatira S; Studer M; Porto MP; Lagutin O; Oliver G
    Genes Dev; 2010 Apr; 24(7):696-707. PubMed ID: 20360386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial ERK signaling controls lymphatic fate specification.
    Deng Y; Atri D; Eichmann A; Simons M
    J Clin Invest; 2013 Mar; 123(3):1202-15. PubMed ID: 23391722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate.
    Hong YK; Harvey N; Noh YH; Schacht V; Hirakawa S; Detmar M; Oliver G
    Dev Dyn; 2002 Nov; 225(3):351-7. PubMed ID: 12412020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos.
    Yang Y; García-Verdugo JM; Soriano-Navarro M; Srinivasan RS; Scallan JP; Singh MK; Epstein JA; Oliver G
    Blood; 2012 Sep; 120(11):2340-8. PubMed ID: 22859612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of FLCN inhibits canonical WNT signaling via TFE3.
    Kennedy JC; Khabibullin D; Hougard T; Nijmeh J; Shi W; Henske EP
    Hum Mol Genet; 2019 Oct; 28(19):3270-3281. PubMed ID: 31272105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic endothelial differentiation: start out with Sox--carry on with Prox.
    Kiefer F; Adams RH
    Genome Biol; 2008; 9(12):243. PubMed ID: 19138383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.
    Shin JW; Min M; Larrieu-Lahargue F; Canron X; Kunstfeld R; Nguyen L; Henderson JE; Bikfalvi A; Detmar M; Hong YK
    Mol Biol Cell; 2006 Feb; 17(2):576-84. PubMed ID: 16291864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature.
    Koltowska K; Betterman KL; Harvey NL; Hogan BM
    Development; 2013 May; 140(9):1857-70. PubMed ID: 23571211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergence of zebrafish and mouse lymphatic cell fate specification pathways.
    van Impel A; Zhao Z; Hermkens DM; Roukens MG; Fischer JC; Peterson-Maduro J; Duckers H; Ober EA; Ingham PW; Schulte-Merker S
    Development; 2014 Mar; 141(6):1228-38. PubMed ID: 24523456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology. Lymphatics are in my veins.
    Simons M; Eichmann A
    Science; 2013 Aug; 341(6146):622-4. PubMed ID: 23929973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.